Sjöberg A, Oscarsson J, Borén J, Edén S, Olofsson S O
Department of Medical Biochemistry, Góteborg University, Sweden.
J Lipid Res. 1996 Feb;37(2):275-89.
Hypophysectomized female rats were treated for 1 week with thyroxine (10 micrograms/kg.day), cortisol (400 micrograms/kg.day), and bovine GH (1 mg/kg.day) either as two daily subcutaneous injections (GH x 2) or as a continuous subcutaneous infusion (GHc) in order to mimic the male and female specific GH secretory patterns, respectively. Hepatocytes were then isolated and kept in short-term cultures. Hypophysectomy decreased the synthesis of triacylglycerol. Treatment with GH x 2 had no or small effects, while GHc normalized the effect of hypophysectomy. ApoB-100 VLDL was assembled before apoB-48 VLDL. ApoB-48 was first assembled as an HDL particle (apoB-48 "HDL"). Hypophysectomy decreased the proportion of intracellular apoB-48 that was recovered as VLDL. Moreover, the proportion of apoB-48 of total apoB in VLDL decreased. Only GHc fully restored the effect of hypophysectomy by inducing an 4-fold increase in the assembly of apoB-48 VLDL, while treatment with GH x 2 gave rise to a 1.8-fold increase. Hypophysectomy resulted in a decrease in the proportion of apoB-48 that was secreted as VLDL and a decrease in the proportion of apoB-48 of total apoB in VLDL. Only treatment with GHc fully restored the secretion of apoB-48 VLDL by inducing an almost 4-fold increase in the secretion of apoB-48 VLDL, while the corresponding value for treatment with GH x 2 was 1.7. However, GH x 2 increased the proportion of the secreted apoB-48 that was recovered in VLDL to the levels found in normal rats and in rats treated with GHc, but this finding was due to a failure of GH x 2 treatment to increase the secretion of apoB-48 "HDL". In summary, a continuous infusion of GH to hypophysectomized rats, mimicking the female secretion of GH, normalized the triacylglycerol synthesis and secretion as well as apoB-48 VLDL assembly and secretion to those levels observed in hepatocyte cultures from intact female rats.
将切除垂体的雌性大鼠用甲状腺素(10微克/千克·天)、皮质醇(400微克/千克·天)和牛生长激素(1毫克/千克·天)治疗1周,生长激素的给药方式分别为每日两次皮下注射(GH x 2)或持续皮下输注(GHc),以分别模拟雄性和雌性特定的生长激素分泌模式。然后分离肝细胞并进行短期培养。切除垂体降低了三酰甘油的合成。GH x 2治疗无作用或作用较小,而GHc使切除垂体的影响恢复正常。载脂蛋白B-100极低密度脂蛋白(VLDL)在载脂蛋白B-48极低密度脂蛋白之前组装。载脂蛋白B-48首先作为高密度脂蛋白颗粒(载脂蛋白B-48“HDL”)组装。切除垂体降低了以极低密度脂蛋白形式回收的细胞内载脂蛋白B-48的比例。此外,极低密度脂蛋白中载脂蛋白B-48占总载脂蛋白B的比例降低。只有GHc通过诱导载脂蛋白B-48极低密度脂蛋白组装增加4倍,完全恢复了切除垂体的影响,而GH x 2治疗使载脂蛋白B-48极低密度脂蛋白组装增加了1.8倍。切除垂体导致以极低密度脂蛋白形式分泌的载脂蛋白B-48比例降低,以及极低密度脂蛋白中载脂蛋白B-48占总载脂蛋白B的比例降低。只有GHc治疗通过诱导载脂蛋白B-48极低密度脂蛋白分泌增加近4倍,完全恢复了载脂蛋白B-48极低密度脂蛋白的分泌,而GH x 2治疗的相应值为1.7。然而,GH x 2将分泌的载脂蛋白B-48在极低密度脂蛋白中回收的比例提高到正常大鼠和接受GHc治疗的大鼠中的水平,但这一发现是由于GH x 2治疗未能增加载脂蛋白B-48“HDL”的分泌。总之,向切除垂体的大鼠持续输注生长激素,模拟雌性生长激素分泌,使三酰甘油的合成和分泌以及载脂蛋白B-48极低密度脂蛋白的组装和分泌恢复到完整雌性大鼠肝细胞培养物中观察到的水平。